Petar Brlek

577 total citations
27 papers, 324 citations indexed

About

Petar Brlek is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Petar Brlek has authored 27 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in Petar Brlek's work include Mesenchymal stem cell research (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Genomics and Rare Diseases (3 papers). Petar Brlek is often cited by papers focused on Mesenchymal stem cell research (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Genomics and Rare Diseases (3 papers). Petar Brlek collaborates with scholars based in Croatia, United States and Bosnia and Herzegovina. Petar Brlek's co-authors include Dragan Primorac, Vilim Molnar, Vid Matišić, Anja Kafka, Nives Pećina‐Šlaus, Anja Bukovac, Marijo Parčina, Ivana Erceg Ivkošić, Vedrana Škaro and Nidhi Shah and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Petar Brlek

23 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petar Brlek Croatia 9 92 75 48 48 41 27 324
Lixia Zhu China 13 113 1.2× 88 1.2× 24 0.5× 42 0.9× 57 1.4× 54 427
Daniel Marrero–Rodríguez Mexico 12 144 1.6× 25 0.3× 75 1.6× 46 1.0× 30 0.7× 43 404
Alexandra Kolenová Slovakia 10 77 0.8× 33 0.4× 30 0.6× 35 0.7× 21 0.5× 40 332
V. Gérolami France 14 84 0.9× 74 1.0× 109 2.3× 34 0.7× 31 0.8× 26 654
Chenxiong Le United States 8 78 0.8× 66 0.9× 63 1.3× 29 0.6× 46 1.1× 11 512
Kamal Abdolmohammadi Iran 10 82 0.9× 55 0.7× 48 1.0× 58 1.2× 12 0.3× 17 295
Pedro Rodríguez‐Jiménez Spain 10 41 0.4× 58 0.8× 33 0.7× 31 0.6× 7 0.2× 46 294
Kai Duan Canada 13 78 0.8× 47 0.6× 138 2.9× 16 0.3× 79 1.9× 33 515
Marco De Zuani Czechia 13 117 1.3× 62 0.8× 40 0.8× 17 0.4× 24 0.6× 20 419
Junichiro Ohori Japan 12 40 0.4× 40 0.5× 91 1.9× 16 0.3× 20 0.5× 43 329

Countries citing papers authored by Petar Brlek

Since Specialization
Citations

This map shows the geographic impact of Petar Brlek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petar Brlek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petar Brlek more than expected).

Fields of papers citing papers by Petar Brlek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petar Brlek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petar Brlek. The network helps show where Petar Brlek may publish in the future.

Co-authorship network of co-authors of Petar Brlek

This figure shows the co-authorship network connecting the top 25 collaborators of Petar Brlek. A scholar is included among the top collaborators of Petar Brlek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petar Brlek. Petar Brlek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brlek, Petar, Leo Mršić, Mateo Sokač, et al.. (2025). Exploring the Pharmacogenomic Map of Croatia: PGx Clustering of 522-Patient Cohort Based on UMAP + HDBSCAN Algorithm. International Journal of Molecular Sciences. 26(2). 589–589.
2.
3.
Patel, Tejas, et al.. (2025). Therapeutic Potential and Mechanisms of Mesenchymal Stem Cells in Coronary Artery Disease: Narrative Review. International Journal of Molecular Sciences. 26(11). 5414–5414. 1 indexed citations
4.
Brlek, Petar, Vilim Molnar, Beata Halassy, et al.. (2025). Cryopreservation and Validation of Microfragmented Adipose Tissue for Autologous Use in Knee Osteoarthritis Treatment. International Journal of Molecular Sciences. 26(14). 6969–6969.
5.
Brlek, Petar, et al.. (2025). In Silico Validation of OncoOrigin: An Integrative AI Tool for Primary Cancer Site Prediction with Graphical User Interface to Facilitate Clinical Application. International Journal of Molecular Sciences. 26(6). 2568–2568. 1 indexed citations
6.
Brlek, Petar, et al.. (2024). Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives. Cells. 13(6). 504–504. 40 indexed citations
7.
8.
Matišić, Vid, et al.. (2023). Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency. International Journal of Molecular Sciences. 24(17). 13498–13498. 3 indexed citations
9.
Brlek, Petar, et al.. (2023). Successful Treatment of a Rare Cholesterol Homeostasis Disorder Due to CYP27A1 Gene Mutation with Chenodeoxycholic Acid Therapy. Biomedicines. 11(5). 1430–1430. 5 indexed citations
10.
Primorac, Dragan, et al.. (2023). Importance of Cellular Immunity and IFN-γ Concentration in Preventing SARS-CoV-2 Infection and Reinfection: A Cohort Study. Viruses. 15(3). 792–792. 3 indexed citations
11.
Ivkošić, Ivana Erceg, et al.. (2023). Unlocking the Potential of Mesenchymal Stem Cells in Gynecology: Where Are We Now?. Journal of Personalized Medicine. 13(8). 1253–1253. 8 indexed citations
12.
Brlek, Petar, Andrea Skelin, Šime Manola, et al.. (2023). Case report: State-of-the-art risk-modifying treatment of sudden cardiac death in an asymptomatic patient with a mutation in the SCN5A gene and a review of the literature. Frontiers in Cardiovascular Medicine. 10. 1193878–1193878. 3 indexed citations
13.
Dumić-Čule, Ivo, et al.. (2022). Autologous Platelet-Rich Plasma (PRP) for Treating Androgenetic Alopecia: A Novel Treatment Protocol Standardized on 2 Cases. Journal of Clinical Medicine. 11(24). 7327–7327. 5 indexed citations
14.
Molnar, Vilim, Željko Jeleč, Petar Brlek, et al.. (2022). Results of Treating Mild to Moderate Knee Osteoarthritis with Autologous Conditioned Adipose Tissue and Leukocyte-Poor Platelet-Rich Plasma. Journal of Personalized Medicine. 13(1). 47–47. 3 indexed citations
15.
Molnar, Vilim, Vid Matišić, Roko Bjelica, et al.. (2022). Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review. Genes. 13(6). 949–949. 49 indexed citations
16.
Primorac, Dragan, Petar Brlek, Vid Matišić, et al.. (2022). Cellular Immunity—The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination. Vaccines. 10(3). 442–442. 21 indexed citations
17.
Polančec, Denis, Damir Hudetz, Željko Jeleč, et al.. (2022). Medicinal signaling cells niche in stromal vascular fraction from lipoaspirate and microfragmented counterpart. Croatian Medical Journal. 63(3). 265–272. 5 indexed citations
18.
Matišić, Vid, Petar Brlek, Vilim Molnar, et al.. (2022). Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study. Croatian Medical Journal. 63(3). 257–264. 5 indexed citations
19.
Polančec, Denis, Damir Hudetz, Željko Jeleč, et al.. (2021). Polychromatic Flow Cytometric Analysis of Stromal Vascular Fraction from Lipoaspirate and Microfragmented Counterparts Reveals Sex-Related Immunophenotype Differences. Genes. 12(12). 1999–1999. 9 indexed citations
20.
Brlek, Petar, Darko Antičević, Vilim Molnar, et al.. (2021). X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in PLS3. Genes. 12(12). 1851–1851. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lixia Zhu Breakdown of academic impact, for papers by Daniel Marrero–Rodríguez Breakdown of academic impact, for papers by Alexandra Kolenová Breakdown of academic impact, for papers by V. Gérolami Breakdown of academic impact, for papers by Chenxiong Le Breakdown of academic impact, for papers by Kamal Abdolmohammadi Breakdown of academic impact, for papers by Pedro Rodríguez‐Jiménez Breakdown of academic impact, for papers by Kai Duan Breakdown of academic impact, for papers by Marco De Zuani Breakdown of academic impact, for papers by Junichiro Ohori
Rankless by CCL
2026